APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Arbidol Tablets (COVID-19)

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Arbidol Tablets (COVID-19) Industry Growth and Trends Forecast to 2032

Report ID 173967120119 December 202575 pages

Choose your research edition.

Industry ResearchArbidol Tablets (COVID-19) Industry Research Report 2026108 pages · $2,950 USDIndustry Growth & TrendsGlobal Arbidol Tablets (COVID-19) Industry Growth and Trends Forecast to 203275 pages · $3,450 USDMarket StructureGlobal Arbidol Tablets (COVID-19) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032177 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Arbidol Tablets (COVID-19) Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Arbidol Tablets (COVID-19) Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Arbidol Tablets (COVID-19) market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Arbidol Tablets (COVID-19) is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Arbidol Tablets (COVID-19) is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Arbidol Tablets (COVID-19) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Arbidol Tablets (COVID-19) include Simcere Pharmaceutical, CSPC Ouyi Pharmaceutical, Jiangsu Wuzhong Pharmaceutical and JSC Pharmstandard, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Arbidol Tablets (COVID-19) market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Arbidol Tablets (COVID-19) market size, estimates, and forecasts are presented in terms of sales volume (M Pcs) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Arbidol Tablets (COVID-19) market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Arbidol Tablets (COVID-19).

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Arbidol Tablets (COVID-19) market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Arbidol Tablets (COVID-19) Market by Company

Simcere Pharmaceutical

CSPC Ouyi Pharmaceutical

Jiangsu Wuzhong Pharmaceutical

JSC Pharmstandard

Arbidol Tablets (COVID-19) Segment by Type

50mg

100mg

Arbidol Tablets (COVID-19) Segment by Application

Anti Influenza Virus

COVID-19

Arbidol Tablets (COVID-19) Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Arbidol Tablets (COVID-19) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Arbidol Tablets (COVID-19) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Arbidol Tablets (COVID-19).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Arbidol Tablets (COVID-19) manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Arbidol Tablets (COVID-19) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 50mg Table 2. Major Company of 100mg Table 3. Global Arbidol Tablets (COVID-19) Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Arbidol Tablets (COVID-19) Sales by Type (2021-2026) & (M Pcs) Table 5. Global Arbidol Tablets (COVID-19) Sales Market Share in Volume by Type (2021-2026) Table 6. Global Arbidol Tablets (COVID-19) Sales by Type (2021-2026) & (US$ Million) Table 7. Global Arbidol Tablets (COVID-19) Sales Market Share in Value by Type (2021-2026) Table 8. Global Arbidol Tablets (COVID-19) Price by Type (2021-2026) & (US$/Pcs) Table 9. Global Arbidol Tablets (COVID-19) Sales by Type (2027-2032) & (M Pcs) Table 10. Global Arbidol Tablets (COVID-19) Sales Market Share in Volume by Type (2027-2032) Table 11. Global Arbidol Tablets (COVID-19) Sales by Type (2027-2032) & (US$ Million) Table 12. Global Arbidol Tablets (COVID-19) Sales Market Share in Value by Type (2027-2032) Table 13. Global Arbidol Tablets (COVID-19) Price by Type (2027-2032) & (US$/Pcs) Table 14. North America Arbidol Tablets (COVID-19) Sales by Type (2021-2026) & (M Pcs) Table 15. North America Arbidol Tablets (COVID-19) Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Arbidol Tablets (COVID-19) Sales by Type (2021-2026) & (M Pcs) Table 17. Europe Arbidol Tablets (COVID-19) Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Arbidol Tablets (COVID-19) Sales by Type (2021-2026) & (M Pcs) Table 19. Asia-Pacific Arbidol Tablets (COVID-19) Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Arbidol Tablets (COVID-19) Sales by Type (2021-2026) & (M Pcs) Table 21. Latin America Arbidol Tablets (COVID-19) Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Arbidol Tablets (COVID-19) Sales by Type (2021-2026) & (M Pcs) Table 23. Middle East and Africa Arbidol Tablets (COVID-19) Sales by Type (2021-2026) & (US$ Million) Table 24. Arbidol Tablets (COVID-19) Industry Trends Table 25. Arbidol Tablets (COVID-19) Industry Drivers Table 26. Arbidol Tablets (COVID-19) Industry Opportunities and Challenges Table 27. Arbidol Tablets (COVID-19) Industry Restraints Table 28. Global Arbidol Tablets (COVID-19) Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Arbidol Tablets (COVID-19) Revenue Market Share by Company (2021-2026) Table 30. Global Arbidol Tablets (COVID-19) Sales by Company (2021-2026) & (M Pcs) Table 31. Global Arbidol Tablets (COVID-19) Sales Share by Company (2021-2026) Table 32. Global Arbidol Tablets (COVID-19) Market Price by Company (2021-2026) & (US$/Pcs) Table 33. Global Arbidol Tablets (COVID-19) Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Arbidol Tablets (COVID-19) Major Company Production Sites and Headquarters Table 35. Global Arbidol Tablets (COVID-19) Company, Product Type & Application Table 36. Global Arbidol Tablets (COVID-19) Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Arbidol Tablets (COVID-19) by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Arbidol Tablets (COVID-19) Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Arbidol Tablets (COVID-19) Sales by Region (2021-2026) & (M Pcs) Table 41. Global Arbidol Tablets (COVID-19) Sales Market Share in Volume by Region (2021-2026) Table 42. Global Arbidol Tablets (COVID-19) Sales by Region (2021-2026) & (US$ Million) Table 43. Global Arbidol Tablets (COVID-19) Sales Market Share in Value by Region (2021-2026) Table 44. Global Arbidol Tablets (COVID-19) Sales (M Pcs), Value (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 45. Global Arbidol Tablets (COVID-19) Sales by Region (2027-2032) & (M Pcs) Table 46. Global Arbidol Tablets (COVID-19) Sales Market Share in Volume by Region (2027-2032) Table 47. Global Arbidol Tablets (COVID-19) Sales by Region (2027-2032) & (US$ Million) Table 48. Global Arbidol Tablets (COVID-19) Sales Market Share in Value by Region (2027-2032) Table 49. Global Arbidol Tablets (COVID-19) Sales (M Pcs), Value (US$ Million), Price (US$/Pcs) and Gross Margin (2027-2032) Table 50. Global Arbidol Tablets (COVID-19) Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Arbidol Tablets (COVID-19) Sales by Application (2021-2026) & (M Pcs) Table 52. Global Arbidol Tablets (COVID-19) Sales Market Share in Volume by Application (2021-2026) Table 53. Global Arbidol Tablets (COVID-19) Sales by Application (2021-2026) & (US$ Million) Table 54. Global Arbidol Tablets (COVID-19) Sales Market Share in Value by Application (2021-2026) Table 55. Global Arbidol Tablets (COVID-19) Price by Application (2021-2026) & (US$/Pcs) Table 56. Global Arbidol Tablets (COVID-19) Sales by Application (2027-2032) & (M Pcs) Table 57. Global Arbidol Tablets (COVID-19) Sales Market Share in Volume by Application (2027-2032) Table 58. Global Arbidol Tablets (COVID-19) Sales by Application (2027-2032) & (US$ Million) Table 59. Global Arbidol Tablets (COVID-19) Sales Market Share in Value by Application (2027-2032) Table 60. Global Arbidol Tablets (COVID-19) Price by Application (2027-2032) & (US$/Pcs) Table 61. North America Arbidol Tablets (COVID-19) Sales by Application (2021-2026) & (M Pcs) Table 62. North America Arbidol Tablets (COVID-19) Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Arbidol Tablets (COVID-19) Sales by Application (2021-2026) & (M Pcs) Table 64. Europe Arbidol Tablets (COVID-19) Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Arbidol Tablets (COVID-19) Sales by Application (2021-2026) & (M Pcs) Table 66. Asia-Pacific Arbidol Tablets (COVID-19) Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Arbidol Tablets (COVID-19) Sales by Application (2021-2026) & (M Pcs) Table 68. Latin America Arbidol Tablets (COVID-19) Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Arbidol Tablets (COVID-19) Sales by Application (2021-2026) & (M Pcs) Table 70. Middle East and Africa Arbidol Tablets (COVID-19) Sales by Application (2021-2026) & (US$ Million) Table 71. Simcere Pharmaceutical Company Information Table 72. Simcere Pharmaceutical Business Overview Table 73. Simcere Pharmaceutical Arbidol Tablets (COVID-19) Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 74. Simcere Pharmaceutical Arbidol Tablets (COVID-19) Product Portfolio Table 75. Simcere Pharmaceutical Recent Development Table 76. CSPC Ouyi Pharmaceutical Company Information Table 77. CSPC Ouyi Pharmaceutical Business Overview Table 78. CSPC Ouyi Pharmaceutical Arbidol Tablets (COVID-19) Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 79. CSPC Ouyi Pharmaceutical Arbidol Tablets (COVID-19) Product Portfolio Table 80. CSPC Ouyi Pharmaceutical Recent Development Table 81. Jiangsu Wuzhong Pharmaceutical Company Information Table 82. Jiangsu Wuzhong Pharmaceutical Business Overview Table 83. Jiangsu Wuzhong Pharmaceutical Arbidol Tablets (COVID-19) Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 84. Jiangsu Wuzhong Pharmaceutical Arbidol Tablets (COVID-19) Product Portfolio Table 85. Jiangsu Wuzhong Pharmaceutical Recent Development Table 86. JSC Pharmstandard Company Information Table 87. JSC Pharmstandard Business Overview Table 88. JSC Pharmstandard Arbidol Tablets (COVID-19) Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 89. JSC Pharmstandard Arbidol Tablets (COVID-19) Product Portfolio Table 90. JSC Pharmstandard Recent Development Table 91. North America Arbidol Tablets (COVID-19) Market Size Growth Rate (CAGR) by Country (M Pcs): 2021 VS 2025 VS 2032 Table 92. North America Arbidol Tablets (COVID-19) Sales by Country (2021-2026) & (M Pcs) Table 93. North America Arbidol Tablets (COVID-19) Sales Market Share by Country (2021-2026) Table 94. North America Arbidol Tablets (COVID-19) Sales Forecast by Country (2027-2032) & (M Pcs) Table 95. North America Arbidol Tablets (COVID-19) Sales Market Share Forecast by Country (2027-2032) Table 96. North America Arbidol Tablets (COVID-19) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 97. North America Arbidol Tablets (COVID-19) Market Size by Country (2021-2026) & (US$ Million) Table 98. North America Arbidol Tablets (COVID-19) Market Share by Country (2021-2026) Table 99. North America Arbidol Tablets (COVID-19) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 100. North America Arbidol Tablets (COVID-19) Market Share Forecast by Country (2027-2032) Table 101. Europe Arbidol Tablets (COVID-19) Market Size Growth Rate (CAGR) by Country (M Pcs): 2021 VS 2025 VS 2032 Table 102. Europe Arbidol Tablets (COVID-19) Sales by Country (2021-2026) & (M Pcs) Table 103. Europe Arbidol Tablets (COVID-19) Sales Market Share by Country (2021-2026) Table 104. Europe Arbidol Tablets (COVID-19) Sales Forecast by Country (2027-2032) & (M Pcs) Table 105. Europe Arbidol Tablets (COVID-19) Sales Market Share Forecast by Country (2027-2032) Table 106. Europe Arbidol Tablets (COVID-19) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 107. Europe Arbidol Tablets (COVID-19) Market Size by Country (2021-2026) & (US$ Million) Table 108. Europe Arbidol Tablets (COVID-19) Market Share by Country (2021-2026) Table 109. Europe Arbidol Tablets (COVID-19) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 110. Europe Arbidol Tablets (COVID-19) Market Share Forecast by Country (2027-2032) Table 111. Asia-Pacific Arbidol Tablets (COVID-19) Market Size Growth Rate (CAGR) by Country (M Pcs): 2021 VS 2025 VS 2032 Table 112. Asia-Pacific Arbidol Tablets (COVID-19) Sales by Country (2021-2026) & (M Pcs) Table 113. Asia-Pacific Arbidol Tablets (COVID-19) Sales Market Share by Country (2021-2026) Table 114. Asia-Pacific Arbidol Tablets (COVID-19) Sales Forecast by Country (2027-2032) & (M Pcs) Table 115. Asia-Pacific Arbidol Tablets (COVID-19) Sales Market Share Forecast by Country (2027-2032) Table 116. Asia-Pacific Arbidol Tablets (COVID-19) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 117. Asia-Pacific Arbidol Tablets (COVID-19) Market Size by Country (2021-2026) & (US$ Million) Table 118. Asia-Pacific Arbidol Tablets (COVID-19) Market Share by Country (2021-2026) Table 119. Asia-Pacific Arbidol Tablets (COVID-19) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 120. Asia-Pacific Arbidol Tablets (COVID-19) Market Share Forecast by Country (2027-2032) Table 121. Latin America Arbidol Tablets (COVID-19) Market Size Growth Rate (CAGR) by Country (M Pcs): 2021 VS 2025 VS 2032 Table 122. Latin America Arbidol Tablets (COVID-19) Sales by Country (2021-2026) & (M Pcs) Table 123. Latin America Arbidol Tablets (COVID-19) Sales Market Share by Country (2021-2026) Table 124. Latin America Arbidol Tablets (COVID-19) Sales Forecast by Country (2027-2032) & (M Pcs) Table 125. Latin America Arbidol Tablets (COVID-19) Sales Market Share Forecast by Country (2027-2032) Table 126. Latin America Arbidol Tablets (COVID-19) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. Latin America Arbidol Tablets (COVID-19) Market Size by Country (2021-2026) & (US$ Million) Table 128. Latin America Arbidol Tablets (COVID-19) Market Share by Country (2021-2026) Table 129. Latin America Arbidol Tablets (COVID-19) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. Latin America Arbidol Tablets (COVID-19) Market Share Forecast by Country (2027-2032) Table 131. Middle East and Africa Arbidol Tablets (COVID-19) Market Size Growth Rate (CAGR) by Country (M Pcs): 2021 VS 2025 VS 2032 Table 132. Middle East and Africa Arbidol Tablets (COVID-19) Sales by Country (2021-2026) & (M Pcs) Table 133. Middle East and Africa Arbidol Tablets (COVID-19) Sales Market Share by Country (2021-2026) Table 134. Middle East and Africa Arbidol Tablets (COVID-19) Sales Forecast by Country (2027-2032) & (M Pcs) Table 135. Middle East and Africa Arbidol Tablets (COVID-19) Sales Market Share Forecast by Country (2027-2032) Table 136. Middle East and Africa Arbidol Tablets (COVID-19) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Middle East and Africa Arbidol Tablets (COVID-19) Market Size by Country (2021-2026) & (US$ Million) Table 138. Middle East and Africa Arbidol Tablets (COVID-19) Market Share by Country (2021-2026) Table 139. Middle East and Africa Arbidol Tablets (COVID-19) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Middle East and Africa Arbidol Tablets (COVID-19) Market Share Forecast by Country (2027-2032) Table 141. Key Raw Materials Table 142. Raw Materials Key Suppliers Table 143. Arbidol Tablets (COVID-19) Distributors List Table 144. Arbidol Tablets (COVID-19) Customers List Table 145. Research Programs/Design for This Report Table 146. Authors List of This Report Table 147. Secondary Sources Table 148. Primary Sources List of Figures Figure 1. Arbidol Tablets (COVID-19) Image Figure 2. Global Arbidol Tablets (COVID-19) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Arbidol Tablets (COVID-19) Market Size (2021-2032) & (US$ Million) Figure 4. Global Arbidol Tablets (COVID-19) Sales (2021-2032) & (M Pcs) Figure 5. 50mg Image Figure 6. Global 50mg Sales YoY Growth (2021-2032) & (M Pcs) Figure 7. 100mg Image Figure 8. Global 100mg Sales YoY Growth (2021-2032) & (M Pcs) Figure 9. Global Arbidol Tablets (COVID-19) Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Arbidol Tablets (COVID-19) Market Share by Type 2025 VS 2032 Figure 11. North America Arbidol Tablets (COVID-19) Sales Market Share in Volume by Type in 2025 Figure 12. North America Arbidol Tablets (COVID-19) Sales Market Share in Value by Type in 2025 Figure 13. Europe Arbidol Tablets (COVID-19) Sales Market Share in Volume by Type in 2025 Figure 14. Europe Arbidol Tablets (COVID-19) Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Arbidol Tablets (COVID-19) Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Arbidol Tablets (COVID-19) Sales Market Share in Value by Type in 2025 Figure 17. Latin America Arbidol Tablets (COVID-19) Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Arbidol Tablets (COVID-19) Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Arbidol Tablets (COVID-19) Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Arbidol Tablets (COVID-19) Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Arbidol Tablets (COVID-19) Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Anti Influenza Virus Image Figure 24. Global Anti Influenza Virus Sales YoY Growth (2021-2032) & (M Pcs) Figure 25. COVID-19 Image Figure 26. Global COVID-19 Sales YoY Growth (2021-2032) & (M Pcs) Figure 27. Global Arbidol Tablets (COVID-19) Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Arbidol Tablets (COVID-19) Market Share by Application 2025 VS 2032 Figure 29. North America Arbidol Tablets (COVID-19) Sales Market Share in Volume by Application in 2025 Figure 30. North America Arbidol Tablets (COVID-19) Sales Market Share in Value by Application in 2025 Figure 31. Europe Arbidol Tablets (COVID-19) Sales Market Share in Volume by Application in 2025 Figure 32. Europe Arbidol Tablets (COVID-19) Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Arbidol Tablets (COVID-19) Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Arbidol Tablets (COVID-19) Sales Market Share in Value by Application in 2025 Figure 35. Latin America Arbidol Tablets (COVID-19) Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Arbidol Tablets (COVID-19) Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Arbidol Tablets (COVID-19) Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Arbidol Tablets (COVID-19) Sales Market Share in Value by Application in 2025 Figure 39. North America Arbidol Tablets (COVID-19) Sales by Country: 2021 VS 2025 VS 2032 (M Pcs) Figure 40. North America Arbidol Tablets (COVID-19) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Arbidol Tablets (COVID-19) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Arbidol Tablets (COVID-19) Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Arbidol Tablets (COVID-19) Sales by Country: 2021 VS 2025 VS 2032 (M Pcs) Figure 44. Europe Arbidol Tablets (COVID-19) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Arbidol Tablets (COVID-19) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Arbidol Tablets (COVID-19) Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Arbidol Tablets (COVID-19) Sales by Country: 2021 VS 2025 VS 2032 (M Pcs) Figure 48. Asia-Pacific Arbidol Tablets (COVID-19) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Arbidol Tablets (COVID-19) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Arbidol Tablets (COVID-19) Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Arbidol Tablets (COVID-19) Sales by Country: 2021 VS 2025 VS 2032 (M Pcs) Figure 52. Latin America Arbidol Tablets (COVID-19) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Arbidol Tablets (COVID-19) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Arbidol Tablets (COVID-19) Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Arbidol Tablets (COVID-19) Sales by Country: 2021 VS 2025 VS 2032 (M Pcs) Figure 56. Middle East and Africa Arbidol Tablets (COVID-19) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Arbidol Tablets (COVID-19) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Arbidol Tablets (COVID-19) Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Arbidol Tablets (COVID-19) Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Arbidol Tablets (COVID-19) Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • 50mg
  • 100mg
Applications
  • Anti Influenza Virus
  • COVID-19
Companies covered
  • Simcere Pharmaceutical
  • CSPC Ouyi Pharmaceutical
  • Jiangsu Wuzhong Pharmaceutical
  • JSC Pharmstandard

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Arbidol Tablets (COVID-19) Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Arbidol Tablets (COVID-19) Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Arbidol Tablets (COVID-19) Market by Type
  6. 1.3.1 50mg
  7. 1.3.2 100mg
  8. 1.4 Global Arbidol Tablets (COVID-19) Market Size by Type
  9. 1.4.1 Global Arbidol Tablets (COVID-19) Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Arbidol Tablets (COVID-19) Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Arbidol Tablets (COVID-19) Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Arbidol Tablets (COVID-19) Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Arbidol Tablets (COVID-19) Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Arbidol Tablets (COVID-19) Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Arbidol Tablets (COVID-19) Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Arbidol Tablets (COVID-19) Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Arbidol Tablets (COVID-19) Industry Trends
  2. 2.2 Arbidol Tablets (COVID-19) Industry Drivers
  3. 2.3 Arbidol Tablets (COVID-19) Industry Opportunities and Challenges
  4. 2.4 Arbidol Tablets (COVID-19) Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Arbidol Tablets (COVID-19) Revenue (2021-2026)
  2. 3.2 Global Top Players by Arbidol Tablets (COVID-19) Sales (2021-2026)
  3. 3.3 Global Top Players by Arbidol Tablets (COVID-19) Price (2021-2026)
  4. 3.4 Global Arbidol Tablets (COVID-19) Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Arbidol Tablets (COVID-19) Major Company Production Sites & Headquarters
  6. 3.6 Global Arbidol Tablets (COVID-19) Company, Product Type & Application
  7. 3.7 Global Arbidol Tablets (COVID-19) Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Arbidol Tablets (COVID-19) Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Arbidol Tablets (COVID-19) Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Arbidol Tablets (COVID-19) Tier 1, Tier 2, and Tier 3
4 Arbidol Tablets (COVID-19) Regional Status and Outlook
  1. 4.1 Global Arbidol Tablets (COVID-19) Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Arbidol Tablets (COVID-19) Historic Market Size by Region
  3. 4.2.1 Global Arbidol Tablets (COVID-19) Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Arbidol Tablets (COVID-19) Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Arbidol Tablets (COVID-19) Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Arbidol Tablets (COVID-19) Forecasted Market Size by Region
  7. 4.3.1 Global Arbidol Tablets (COVID-19) Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Arbidol Tablets (COVID-19) Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Arbidol Tablets (COVID-19) Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Arbidol Tablets (COVID-19) by Application
  1. 5.1 Arbidol Tablets (COVID-19) Market by Application
  2. 5.1.1 Anti Influenza Virus
  3. 5.1.2 COVID-19
  4. 5.2 Global Arbidol Tablets (COVID-19) Market Size by Application
  5. 5.2.1 Global Arbidol Tablets (COVID-19) Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Arbidol Tablets (COVID-19) Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Arbidol Tablets (COVID-19) Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Arbidol Tablets (COVID-19) Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Arbidol Tablets (COVID-19) Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Arbidol Tablets (COVID-19) Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Arbidol Tablets (COVID-19) Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Arbidol Tablets (COVID-19) Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Simcere Pharmaceutical
  2. 6.1.1 Simcere Pharmaceutical Company Information
  3. 6.1.2 Simcere Pharmaceutical Business Overview
  4. 6.1.3 Simcere Pharmaceutical Arbidol Tablets (COVID-19) Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Simcere Pharmaceutical Arbidol Tablets (COVID-19) Product Portfolio
  6. 6.1.5 Simcere Pharmaceutical Recent Developments
  7. 6.2 CSPC Ouyi Pharmaceutical
  8. 6.2.1 CSPC Ouyi Pharmaceutical Company Information
  9. 6.2.2 CSPC Ouyi Pharmaceutical Business Overview
  10. 6.2.3 CSPC Ouyi Pharmaceutical Arbidol Tablets (COVID-19) Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 CSPC Ouyi Pharmaceutical Arbidol Tablets (COVID-19) Product Portfolio
  12. 6.2.5 CSPC Ouyi Pharmaceutical Recent Developments
  13. 6.3 Jiangsu Wuzhong Pharmaceutical
  14. 6.3.1 Jiangsu Wuzhong Pharmaceutical Company Information
  15. 6.3.2 Jiangsu Wuzhong Pharmaceutical Business Overview
  16. 6.3.3 Jiangsu Wuzhong Pharmaceutical Arbidol Tablets (COVID-19) Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Jiangsu Wuzhong Pharmaceutical Arbidol Tablets (COVID-19) Product Portfolio
  18. 6.3.5 Jiangsu Wuzhong Pharmaceutical Recent Developments
  19. 6.4 JSC Pharmstandard
  20. 6.4.1 JSC Pharmstandard Company Information
  21. 6.4.2 JSC Pharmstandard Business Overview
  22. 6.4.3 JSC Pharmstandard Arbidol Tablets (COVID-19) Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 JSC Pharmstandard Arbidol Tablets (COVID-19) Product Portfolio
  24. 6.4.5 JSC Pharmstandard Recent Developments
7 North America by Country
  1. 7.1 North America Arbidol Tablets (COVID-19) Sales by Country
  2. 7.1.1 North America Arbidol Tablets (COVID-19) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Arbidol Tablets (COVID-19) Sales by Country (2021-2026)
  4. 7.1.3 North America Arbidol Tablets (COVID-19) Sales Forecast by Country (2027-2032)
  5. 7.2 North America Arbidol Tablets (COVID-19) Market Size by Country
  6. 7.2.1 North America Arbidol Tablets (COVID-19) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Arbidol Tablets (COVID-19) Market Size by Country (2021-2026)
  8. 7.2.3 North America Arbidol Tablets (COVID-19) Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Arbidol Tablets (COVID-19) Sales by Country
  2. 8.1.1 Europe Arbidol Tablets (COVID-19) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Arbidol Tablets (COVID-19) Sales by Country (2021-2026)
  4. 8.1.3 Europe Arbidol Tablets (COVID-19) Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Arbidol Tablets (COVID-19) Market Size by Country
  6. 8.2.1 Europe Arbidol Tablets (COVID-19) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Arbidol Tablets (COVID-19) Market Size by Country (2021-2026)
  8. 8.2.3 Europe Arbidol Tablets (COVID-19) Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Arbidol Tablets (COVID-19) Sales by Country
  2. 9.1.1 Asia-Pacific Arbidol Tablets (COVID-19) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Arbidol Tablets (COVID-19) Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Arbidol Tablets (COVID-19) Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Arbidol Tablets (COVID-19) Market Size by Country
  6. 9.2.1 Asia-Pacific Arbidol Tablets (COVID-19) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Arbidol Tablets (COVID-19) Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Arbidol Tablets (COVID-19) Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Arbidol Tablets (COVID-19) Sales by Country
  2. 10.1.1 South America Arbidol Tablets (COVID-19) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Arbidol Tablets (COVID-19) Sales by Country (2021-2026)
  4. 10.1.3 South America Arbidol Tablets (COVID-19) Sales Forecast by Country (2027-2032)
  5. 10.2 South America Arbidol Tablets (COVID-19) Market Size by Country
  6. 10.2.1 South America Arbidol Tablets (COVID-19) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Arbidol Tablets (COVID-19) Market Size by Country (2021-2026)
  8. 10.2.3 South America Arbidol Tablets (COVID-19) Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Arbidol Tablets (COVID-19) Sales by Country
  2. 11.1.1 Middle East and Africa Arbidol Tablets (COVID-19) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Arbidol Tablets (COVID-19) Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Arbidol Tablets (COVID-19) Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Arbidol Tablets (COVID-19) Market Size by Country
  6. 11.2.1 Middle East and Africa Arbidol Tablets (COVID-19) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Arbidol Tablets (COVID-19) Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Arbidol Tablets (COVID-19) Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Arbidol Tablets (COVID-19) Value Chain Analysis
  2. 12.1.1 Arbidol Tablets (COVID-19) Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Arbidol Tablets (COVID-19) Production Mode & Process
  7. 12.2 Arbidol Tablets (COVID-19) Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Arbidol Tablets (COVID-19) Distributors
  10. 12.2.3 Arbidol Tablets (COVID-19) Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst